Revolution Medicines, Inc. Warrant (RVMDW)

• Market cap: $36.7M
• 1 day: -1.40%
• 5 days: 43.21%
• 1 month: 162.93%
• 3 months: 55.64%
• 6 months: -58.05%
• Year to date: 40.86%
• 1 year: 8.59%
• 5 years: -80.28%
• 10 years: -80.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Employees: 616

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0% more funds holding

Funds holding: 24 [Q4 2024] → 24 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.41% less ownership

Funds ownership: 4.56% [Q4 2024] → 4.14% (-0.41%) [Q1 2025]

82% less capital invested

Capital invested by funds: $1.71M [Q4 2024] → $316K (-$1.4M) [Q1 2025]